Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

ACOG Practice Bulletin no. 109: Cervical cytology screening.

ACOG Committee on Practice Bulletins--Gynecology..

Obstet Gynecol. 2009 Dec;114(6):1409-20. doi: 10.1097/AOG.0b013e3181c6f8a4. No abstract available.

PMID:
20134296
2.

The psychosocial burden of human papillomavirus related disease and screening interventions.

Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, Garland S.

Sex Transm Infect. 2009 Dec;85(7):508-13. doi: 10.1136/sti.2009.037028. Epub 2009 Aug 24.

PMID:
19703844
3.

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J.

Lancet Oncol. 2009 Jul;10(7):672-82. doi: 10.1016/S1470-2045(09)70156-1. Epub 2009 Jun 17. Erratum in: Lancet Oncol. 2009 Aug;10(8):748.

PMID:
19540162
4.

Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity.

Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A.

Cancer Causes Control. 2009 Sep;20(7):1129-38. doi: 10.1007/s10552-009-9317-z. Epub 2009 Mar 1.

PMID:
19253025
5.

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.

Havrilesky LJ, Broadwater G, Davis DM, Nolte KC, Barnett JC, Myers ER, Kulasingam S.

Gynecol Oncol. 2009 May;113(2):216-20. doi: 10.1016/j.ygyno.2008.12.026. Epub 2009 Feb 12.

6.

ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology.

American College of Obstetricians and Gynecologists..

Obstet Gynecol. 2008 Dec;112(6):1419-44. doi: 10.1097/AOG.0b013e318192497c.

PMID:
19037054
7.

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference..

J Low Genit Tract Dis. 2007 Oct;11(4):223-39. Erratum in: J Low Genit Tract Dis. 2008 Jan;12(1):63.

PMID:
17917567
8.

Effect of noncancerous pelvic problems on health-related quality of life and sexual functioning.

Kuppermann M, Learman LA, Schembri M, Gregorich S, Jacoby A, Jackson RA, Gates E, Wassel-Fyr C, Lewis J, Washington AE.

Obstet Gynecol. 2007 Sep;110(3):633-42.

PMID:
17766611
9.
10.

Abnormal outcomes following cervical cancer screening: event duration and health utility loss.

Insinga RP, Glass AG, Myers ER, Rush BB.

Med Decis Making. 2007 Jul-Aug;27(4):414-22. Epub 2007 Jun 21.

PMID:
17585005
11.
12.

How do women of diverse backgrounds value prenatal testing outcomes?

Kuppermann M, Nease Jr RF, Gates E, Learman LA, Blumberg B, Gildengorin V, Washington AE.

Prenat Diagn. 2004 Jun;24(6):424-9.

PMID:
15229840
13.

Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility.

Birch S, Melnikow J, Kuppermann M.

Health Econ. 2003 Oct;12(10):879-84.

PMID:
14508872
14.

Management of the low-grade abnormal Pap smear: What are women's preferences?

Melnikow J, Kuppermann M, Birch S, Chan BK, Nuovo J.

J Fam Pract. 2002 Oct;51(10):849-55.

PMID:
12401153
15.

Measurement of health state utilities for economic appraisal.

Torrance GW.

J Health Econ. 1986 Mar;5(1):1-30. Review.

PMID:
10311607
16.

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment.

Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M.

J Clin Epidemiol. 1998 Nov;51(11):1171-8.

PMID:
9817135
17.

International incidence rates of invasive cervical cancer after introduction of cytological screening.

Gustafsson L, Pontén J, Zack M, Adami HO.

Cancer Causes Control. 1997 Sep;8(5):755-63.

PMID:
9328198
18.

A utility maximization model for evaluation of health care programs.

Torrance GW, Thomas WH, Sackett DL.

Health Serv Res. 1972 Summer;7(2):118-33. No abstract available.

19.

Psychological side effects of breast cancer screening.

Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A.

Health Psychol. 1991;10(4):259-67.

PMID:
1915212

Supplemental Content

Support Center